Preview

Medical Immunology (Russia)

Advanced search

INTERLEUKIN-1β APPLICATION FOR LOCAL TREATMENT OF PURULENT AND NECROTIC LESIONS OF LOWER EXTREMITIES

https://doi.org/10.15789/1563-0625-2008-4-5-439-448

Abstract

Abstract. Treatment of chronic wounds is a difficult problem of contemporary surgery. An opportunity of curing these wounds by means of cytokines, such as interleukin-1 (IL-1), is an issue of great interest. A clinical trial of IL-1β was performed in the patients with chronic wounds of different origin. Recombinant human IL-1β was applied in six ointment compositions containing active drug (0.05 to 5000 ng/ml) using a hydrophobic vehicle. The preparations were used to treat non-healing wounds and trophic ulcers in patients with diseases of lower extremities complicated by venous insufficiency or diabetes type I and II. Clinical examinations, wound area measurements and cytological analysis of wound smears were performed before starting the treatment and in the course of therapy. Clinical results for the wound lesions (2nd and 3rd phases) have demonstrated high efficacy of ointments containing IL-1β at 0.5 to 5000 ng/ml. The most efficient concentration was determined as 50 ng IL-1β in 1 ml of ointment. IL-1β treatment caused clinical improvement of wound healing in 90% of the patients, including those with diabetes. IL-1β application during 2nd and 3rd phases of wound process showed good correlations with cytological changes in wound cell smears. When using IL-1β-containing ointments, the terms of granulation and epithelisation terms were reduced, along with 1.5-fold increase in average healing rates, as compared to conventional treatment with Solcoseril and Vulnusan. Mechanisms of IL-1β action were similar for the patients with wounds of different origin. Application of IL-1β-containing requires daily changes of wound dressings with the ointment. What to complications, local allergic reactions were detected only in 1.9% of cases. To summarize, the results of our study provide an evidence that IL-1β-containing ointment is a useful drug for effective treatment of non-healing wounds and trophic ulcers in patients. (Med. Immunol., vol. 10, N 4-5, pp 439-448).

About the Authors

E. A. Varyushina
ФГУП ГосНИИ ОЧБ ФМБА России, Санкт-Петербург
Russian Federation


E. A. Moskalenko
Санкт-Петербургская медицинская академия последипломного образования
Russian Federation


T. P. Lebedeva
Санкт-Петербургская медицинская академия последипломного образования
Russian Federation


A. N. Bubnov
Санкт-Петербургская медицинская академия последипломного образования
Russian Federation


A. S. Simbirtsev
ФГУП ГосНИИ ОЧБ ФМБА России, Санкт-Петербург
Russian Federation


References

1. Костюченок Б.М., Карлов В.А. Клиника раневого процесса // Раны и раневая инфекция: Рук-во для врачей / Под ред. М.И. Кудрина, Б.М. Костюченка – М.: «Медицина», 1990. – С. 186-221.

2. Даценко Б.М., Бирюкова С.В., Тамм Т.И. Методические рекомендации по экспериментальному изучению лекарственных препаратов для мес тного лечения гнойных ран. – М., 1989. – 46 с.

3. Greenhalgh D.G. Wound healing and diabetes mellitus // Clin. Plast. Surg. – 2003. – Vol. 30. – P. 37-45.

4. Enoch S., Leaper D.J. Basic science of wound healing // Surgery. – 2005. – Vol. 23. – P. 37-42.

5. Jude E.B., Blakytny R., Bulmer J., Boulton A.J., Ferguson M.W. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers // Diabet. Med. – 2002. – Vol. 19. – P. 440-447.

6. Leibovich S.J., Ross R. The role of macrophage in wound repair: a study with hydrocortisone and antimacrophage serum // Am. J. Pathol. – 1975. – Vol. 78. – P. 71-91.

7. Lerman O.Z., Galiano R.D., Armour M., Levine J.P., Gurtner G.C. Cellular dysfunction in the diabetic fibroblast. Impairment in migration, vascular endothelial growth factor production, and response to hypoxia // Am. J. Pathol. – 2003. – Vol. 162. – P. 303-312.

8. Maruyama K., Asai J., Ii M., Thorne T., Losordo D.W., D’Amore P.A. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing // Am. J. Pathol. – 2007. – Vol. 170. – P. 1178-1191.

9. Moore K., Ruge F., Harding K.G. T lymphocytes and the lack of activated macrophages in wound margin biopsies from chronic leg ulcers // Br. J. Dermatol. – 1997. – Vol. 137. – P. 188-194.

10. Nolan C.M., Beaty H.N., Bagdade J.D. Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes // Diabetes. – 1978. – Vol. 27. – Р. 889-894.

11. Ogle J.D., Noel J.G., Balasurbramaniam A., Sramkosty R.M., Ogle C.K., Alexander J.W. Comparison of abilities of recombinant IL-1a and β and noninflammatory IL-1β fragment 163-171 to upregulate C3b receptor (CRI) on human neutrophils to enhance their phagocytic capacity // Inflammation. – 1990. – Vol. 14. – P. 182-194.

12. Sauder D.N., Kilian P.L., McLane J.A., Quick T.W., Jakubovic H., David S.C., Eaglstein W.H., Mertz P.M. Interleukin-1 enhances epidermal wound healing // Lymphokine Res. – 1990. – Vol. 9. – P. 465-473.

13. Simbirtsev A., Variouchina E., Konusova V., Kotov A., Ketlinsky S., Salamatov A., Bisenkov L. Local administration of interleukin-1beta for the treatment of lung abscesses induces neutrophil activation and changes in proinflammatory cytokine production // Eur. Cytokine Netw. – 2001. – Vol. 12. – P. 420-429.

14. Spravchicov N., Sizyakov G., Gartsbein M., Accili D., Tennenbaum T., Wertheimer E. Glucose effects on skin keratinocytes. Implications for diabet skin complications // Diabetes. – 2001. – Vol. 50. – P. 1627-1635.

15. Thornton S.C., Pot S.V., Walsh B.J., Penny R., Breit S.N. Interaction of immune and connective tissue cells: the effects of lymphokines and monokines on fibroblast growth // J. Leuk. Biol. – 1990. – Vol. 47. – P. 312-320.

16. Variouchina E.A., Antsiferova M.A., Aleksandrov G.V., Konusova V.G., Pigareva N.V., Petrov A.V., Simbirtsev A.S. Topical application of interleukine-1β accelerates wound healing in hydrocortisone-treated mice // Russian J. Immunol. – 2003. – Vol. 8. – P. 155-164.

17. Werner S., Breden M., Hubner G., Greenhalgh D.G., Longaker M.T. Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse // J. Invest. Dermatol. – 1994. – Vol. 103. – P. 469-473.


Review

For citations:


Varyushina E.A., Moskalenko E.A., Lebedeva T.P., Bubnov A.N., Simbirtsev A.S. INTERLEUKIN-1β APPLICATION FOR LOCAL TREATMENT OF PURULENT AND NECROTIC LESIONS OF LOWER EXTREMITIES. Medical Immunology (Russia). 2008;10(4-5):439-448. (In Russ.) https://doi.org/10.15789/1563-0625-2008-4-5-439-448

Views: 1138


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)